Abstract: Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

Abstract: Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I as defined herein. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

Abstract: The invention is directed to a class of compounds, including the pharmaceutically acceptable salts of the compounds, having the structure of formula I: as defined in the specification. The invention is also directed to compositions containing and uses of the compounds of formula I.

Abstract: Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I; as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

Abstract: Evacuation slide systems having extendable portions are detailed. The extendable portions of slides may be inflated separately from the main portions and actuated manually if desired. Consequently, attitude changes of, for example, an aircraft subsequent to inflation of the main portion of a slide would not necessarily defeat its use, as inflation of the extendable portion could still occur.

Abstract: The invention is directed to a class of compounds, including the pharmaceutically acceptable salts of the compounds, having the structure of formula (I): as defined in the specification. The invention is also directed to compositions containing the compounds of formula (I). They are useful in the treatment of CNS disorders.

Abstract: The invention is directed to a class of compounds, including the pharmaceutically acceptable salts of the compounds, having the structure of Formula (I): as defined in the specification. The invention is also directed to compositions containing the compounds of Formula (I) as AMPA modulators.

Abstract: The invention is directed to a class of compounds, including the pharmaceutically acceptable salts of the compounds, having the structure of formula I: as defined in the specification. The invention is also directed to compositions containing and uses of the compounds of formula I.

Abstract: A compound of formula I or a pharmaceutically acceptable salt thereof, processes for preparing such compounds, their use as GPR119 modulators, methods for their therapeutic use, particularly in the treatment of obesity and diabetes mellitus, and pharmaceutical compositions containing them.

Abstract: Evacuation slide systems having extendable portions are detailed. The extendable portions of slides may be inflated separately from the main portions and actuated manually if desired. Consequently, attitude changes of, for example, an aircraft subsequent to inflation of the main portion of a slide would not necessarily defeat its use, as inflation of the extendable portion could still occur.

Abstract: Nebivolol has been shown to be beneficial in the treatment of cardiovascular diseases such hypertension, congestive heart failure, arterial stiffness and endothelial dysfunction. The present invention features a pharmaceutical composition comprising nebivolol and at least one other active agent, wherein the at least one other active agent is a cardiovascular agent.

Abstract: Aspirators for inflating devices such as (but not limited to) aircraft evacuation slides and rafts are detailed. Housings of the aspirators may be made of wound filaments of composite materials, reducing their weight as compared to conventional metal structures. Such actions as reconfiguring and repositioning jet nozzles within the housings also contribute to enhancing performance of the aspirators.

Abstract: A mounting bracket is provided for mounting a cladding panel to a structure. The mounting bracket comprises a body (2) having first and second walls (4,6) spaced from one another and a third wall (8) extending between the first and second walls (4,6). A first aperture (24) is located in the first wall (4) and a second aperture (26) is located in the second wall (6). The apertures (24,26) are substantially co-axial and adapted to receive a fixture therein. The mounting member also comprises at least one pair of resilient flanges (12) projecting from the third wall (8), the pair of flanges (12) adapted to clamp a portion of a cladding panel between them. A new fixture for securing such mounting members to the structure is also provided.

Abstract: Nebivolol has been shown to be beneficial in the treatment of cardiovascular diseases such hypertension, congestive heart failure, arterial stiffness and endothelial dysfunction. The present invention features a pharmaceutical composition comprising nebivolol and at least one other active agent, wherein the at least one other active agent is a cardiovascular agent.

Abstract: Nebivolol has been shown to be beneficial in the treatment of cardiovascular diseases such hypertension, congestive heart failure, arterial stiffness and endothelial dysfunction. The present invention features a pharmaceutical composition comprising nebivolol and at least one other active agent, wherein the at least one other active agent is a cardiovascular agent.

Abstract: In an information processing system which has plurality of modules including a processor, a main memory and a plurality of I/O devices, a data transfer switch for performing data transfer operations between the processor, main memory and I/O devices comprises a request bus which has a request bus arbiter for receiving read and write requests from each one of the plurality of modules. A processor memory bus is configured to receive address and data information from a predetermined number of modules, including the processor. The processor memory bus has a data bus arbiter for receiving data read and write requests from each one of the predetermined number of modules which are coupled to the processor memory bus. An internal memory bus is configured to receive address and data information from a predetermined number of modules, including the memory and the I/O devices.

Abstract: A compound of formula I or a pharmaceutically acceptable salt thereof, processes for preparing such compounds, their use as Fatty Acid Synthase inhibitors, methods for their therapeutic use, particularly in the treatment of obesity, diabetes mellitus, cancer and infection and pharmaceutical compositions containing them.

Abstract: A compound of formula I or a pharmaceutically acceptable salt thereof, processes for preparing such compounds, their use as Fatty Acid Synthase inhibitors, methods for their therapeutic use, particularly in the treatment of obesity and diabetes mellitus, cancer and infection and pharmaceutical compositions containing them.

Abstract: An integrated multimedia system having a multimedia processor is disposed in an integrated circuit having a first host processor system coupled to the multimedia processor and a second local processor disposed within the multimedia processor for controlling the operation of the multimedia processor. A data transfer switch is coupled to the second processor for transferring data to various modules of the processor, at least one of which is a data cache. The data transfer switch transfers data in either direction between the cache and a module within the processor. A data streamer schedules simultaneous data transfers among the various-modules disposed within the multimedia processor in accordance with corresponding channel allocations. An interface unit is coupled to the data streamer and has a plurality of input/output (I/O) device driver units. A plurality of external I/O devices are coupled to the plurality of I/O device driver units via a multiplexer.

Abstract: A process for preparing an encapsulated particulate solid using an epoxy functional cross-linking agent and a carboxylic acid functional dispersant wherein the cross-linking agent has one or more oligomeric dispersing group and/or the dispersant has an acid value of at least 125 mg KOH/g. The resultant solids are useful in, for example, ink jet printing inks.